Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Vascular endothelial growth factor (VEGF) has been implicated in inflammatory and airway blood vessel remodeling in asthmatics.
|
27579513 |
2016 |
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
PDGFBB and VEGF levels were significantly associated with asthma.
|
31586492 |
2019 |
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma.
|
22689881 |
2012 |
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Importantly, MFG-E8 apparently alleviated OVA-driven airway remodeling, which were evidenced by declined secretion of important mediators of airway remodeling, including transforming growth factor-β1, matrix metalloproteinase 9, ADAM8, and vascular endothelial growth factor, and reduced airway collagen deposition and inhibited goblet cell hyperplasia in OVA-induced asthma in mice.
|
30076648 |
2018 |
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
These findings provide evidence that VEGF may play an important role in angiogenesis and subsequent airway remodeling in bronchial asthma.
|
11398081 |
2001 |
Asthma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.
|
15201500 |
2004 |
Asthma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: implication in manganese-induced pulmonary inflammation.
|
19263519 |
2009 |
Asthma
|
0.400 |
Biomarker
|
disease |
CTD_human |
One of the histological hallmarks of inflammation is angiogenesis, but the possible role of vascular endothelial growth factor (VEGF), a potent angiogenic cytokine, in TDI-induced asthma is unknown.
|
11907124 |
2002 |
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
The aim of this study was to compare vascular endothelial growth factor (VEGF) and its receptor foetal liver kinase (Flk)-1 expression between seasonal AR patients with or without asthma and non-allergic controls as well as that between AR patients with and without asthma.
|
17651148 |
2007 |
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling.
|
17168735 |
2006 |
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses.
|
16461129 |
2006 |
Asthma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma.
|
18298425 |
2009 |
Asthma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Administration of VEGF receptor inhibitors reduced the pathophysiologic signs of asthma and decreased the increased expression of MMP-9 after ovalbumin inhalation.
|
16645174 |
2006 |
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent.
|
14633511 |
2004 |
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.
|
15201500 |
2004 |